- $261.39m
- $132.58m
- 51
- 21
- 100
- 60
Annual balance sheet for Zura Bio, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | |
| Standards: | — | USG | USG | USG | USG |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | — | 0.729 | 0.014 | 99.8 | 176 |
| Prepaid Expenses | |||||
| Total Current Assets | — | 1.15 | 0.033 | 101 | 179 |
| Net Property, Plant And Equipment | — | — | — | — | 0.091 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | — | 141 | 142 | 101 | 180 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | — | 0.272 | 1.83 | 20.3 | 19.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | — | 10.4 | 7.76 | 41.5 | 32.7 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | — | 130 | 134 | 59.3 | 147 |
| Total Liabilities & Shareholders' Equity | — | 141 | 142 | 101 | 180 |
| Total Common Shares Outstanding |